rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2008-4-22
|
pubmed:abstractText |
Although the incidences of testicular cancer and Hodgkin's lymphoma have increased in young men over the past decade, combination chemotherapy has improved survival. As fertility is of importance to these patients, characterization of sperm chromatin structure is needed. We assessed sperm chromatin in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy, in comparison with control community and idiopathic infertile volunteers.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1460-2350
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1044-52
|
pubmed:meshHeading |
pubmed-meshheading:18346994-Adult,
pubmed-meshheading:18346994-Bicyclo Compounds,
pubmed-meshheading:18346994-Chromatin,
pubmed-meshheading:18346994-Chromomycin A3,
pubmed-meshheading:18346994-Cohort Studies,
pubmed-meshheading:18346994-Comet Assay,
pubmed-meshheading:18346994-DNA Damage,
pubmed-meshheading:18346994-Flow Cytometry,
pubmed-meshheading:18346994-Hodgkin Disease,
pubmed-meshheading:18346994-Humans,
pubmed-meshheading:18346994-In Situ Nick-End Labeling,
pubmed-meshheading:18346994-Infertility, Male,
pubmed-meshheading:18346994-Male,
pubmed-meshheading:18346994-Middle Aged,
pubmed-meshheading:18346994-Sensitivity and Specificity,
pubmed-meshheading:18346994-Spermatozoa,
pubmed-meshheading:18346994-Testicular Neoplasms
|
pubmed:year |
2008
|
pubmed:articleTitle |
Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy.
|
pubmed:affiliation |
Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|